Katie J. Suda
The 2017-2018 SIDP Infectious Diseases Pharmacotherapy Paper Award is given to an SIDP member to recognize a significant contribution to the peer-reviewed literature in infectious diseases pharmacotherapy that has the potential to make a significant impact on future infectious diseases practice and/or research. This year’s recipient and her colleagues performed a national, population-level analysis evaluating antibiotic expenditures by healthcare setting and class. This paper, published in Clinical Infectious Diseases, provides transformative data that the outpatient setting, especially community pharmacies, is the primary health care setting where antibiotics are dispensed. These results indicate that antimicrobial stewardship programs aimed at the community could reduce healthcare costs and decrease inappropriate antibiotic use. This publication has already received recognition of its importance to infectious disease practice and has been highlighted as part of CDC messaging advocating for implementation of outpatient antibiotic stewardship efforts. It is with great pleasure that we present this award to: Dr. Katie Suda for the paper entitled, “Antibiotic Expenditures by Medication, Class, and Healthcare Setting in the United States, 2010-2015.”
Elias B. Chahine
The 2017-2018 SIDP Gita Patel Best Practice Recognition Award was established to honor Dr. Gita Wasan Patel, who committed herself to providing optimal care to patients and was passionate about infectious diseases. The purpose of this award is to recognize an SIDP member who has implemented and documented the impact of an innovative or collaborative “best practice” initiative to improve care in patients with infectious diseases. This year’s recipient is an Associate Professor at Palm Beach Atlantic University and a Clinical Pharmacy Specialist at Wellington Regional Medical Center in Florida. In addition to providing exceptional infectious diseases education, scholarly activities, and services, he has been successful in making a clinical practice impact in the community across the globe. He has led multiple medical mission trips to underserved populations, where he assesses patients for various infectious diseases and provides treatment in many cases. These trips also serve as an avenue for mentoring trainees. He has multiple publications and presentations documenting the medical and spiritual impact of these programs. It is with great pleasure that we present this award to: Dr. Elias Chahine.
Ashley M. Wilde
The 2017-2018 Outstanding Clinical Practice in Infectious Diseases Pharmacotherapy Award is given to recognize an SIDP member who has developed an innovative and/or excellent clinical practice site. This year’s recipient is an Infectious Diseases Clinical Pharmacist at Norton Healthcare in Louisville, Kentucky. She was the first ID pharmacist to bring comprehensive ID and stewardship services to the four-hospital system comprised of over 1500 beds. She has been successful in designing and implementing unique and effective solutions to improve patient care, including a C. difficile transition of care program, rapid bacteremia response program, and an MRSA infection practice guideline for therapeutic interchanges. She also created a prospective audit & feedback system that couples customized electronic antibiotic recommendations, allowing the ID pharmacist to implement recommendations if no provider declines. Her initiatives have led to significant and sustained reductions in antibiotic use and healthcare costs. Her cost containment efforts spurred expanded clinical services in the system, including 3 additional ID pharmacists and a PGY2 infectious diseases residency program. It is with great pleasure that we present this award to: Dr. Ashley Wilde.
Brian J. Werth
The 2017-2018 SIDP Young Investigator Award is given to a young investigator who shows research promise in the broad area of infectious diseases. This year’s awardee has demonstrated tremendous research productivity over the past 5 years at the University of Washington School of Pharmacy. His multidisciplinary, translational research program has focused on antimicrobial dosing strategies that optimize efficacy and prevent or overcome resistance in multidrug resistant pathogens. Since beginning his academic appointment, he has published 22 peer-reviewed papers and received research support from SIDP, pharmaceutical industry, and the National Institutes of Health. He was recently awarded a 4-year, $1.86 million NIH R01 grant as principal investigator, which is an exceptional accomplishment for a young investigator. He also has made significant contributions to infectious diseases research through education, mentorship, and service. It is with great pleasure that we present this award to: Dr. Brian Werth.